Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124936) titled 'fNIRS as a biomarker for individuals with subjective cognitive decline and MCI' on May 19.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: The First Affiliated Hospital of Xiamen University
Condition:
Mild Cognitive Impairment
Intervention:
Mild Cognitive Impairment group:No
Healthy control group:No
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-20
Target Sample Size: Mild Cognitive Impairment group:24;Healthy control group:24;Subjective Cognitive Decline group:24;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...